http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20060021016-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_012a5102e6191263979900b8c7572fd2 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-485 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-485 |
filingDate | 2004-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3576b6072b5a16af47af57969205c87c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2eaec44cf2f7ca86e4b3f78e2b44400f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cea304ecd7383d078837445b21c62eb5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b82c0654f871f82256f13e51e485fa18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31aca01791f4078c776b46037eb3893a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55a6d00842da534b8acb14fa659f40ce http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de8fb44b548ecfbdd481a8447addfae1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36d50a62144a630a8d2197369c909e0f |
publicationDate | 2006-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-20060021016-A |
titleOfInvention | Epithelial growth factor-polyethylene glycol conjugate and method for preparing the same |
abstract | The present invention relates to an epidermal growth factor-polyethylene glycol conjugate and a method for preparing the same, and more particularly, to a specific portion of an epidermal growth factor (EGF) derived from humans, that is, an amine group of lysine. And / or epithelial growth factor-polyethyleneglycol conjugates in which covalently bonded polyethylene glycol (PEG, Polyethylene Glycol), which is a polymer, to an amino-terminal amine group and a method for preparing the same. Therefore, the epidermal growth factor-polyethylene glycol conjugate according to the present invention can lower the degree of degradation in vivo as compared to the natural epidermal growth factor, and is remarkably stable against physicochemical factors such as heat, acid, and alkali, even outside the body. The effect can be obtained.n n n n Polyethylene glycol, epidermal growth factor, EGF, pegylation reaction, pegylation |
priorityDate | 2004-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 43.